Europe Pharmaceutical Drug Delivery Market Growth Opportunities and Forecast by 2027

The Europe pharmaceutical drug delivery market is anticipated to reach US$ 562,102.6 Mn by 2027 from US$ 352,775.1 Mn in 2019; the market is projected to grow at a CAGR of 6.2% during 2020–2027.

The growth of the pharmaceutical drug delivery market is primarily attributed to the increase in the number of naturally occurring outbreaks. However, the rising cases of needlestick injuries and infections hamper the growth of the market. Further, strategic activities by manufacturers are expected to have a positive impact on the growth of the Europe pharmaceutical drug delivery market in the coming years.

Disease outbreaks are generally caused by an infection transmitted through animal-to-person or person-to-person contact, or from the environment or other media. Through its report in 2017, the World Health Organization warned that infectious diseases are emerging at a rate that has not been seen before. Since the 1970s, ~40 contagious diseases have been discovered, including SARS, MERS, Ebola, chikungunya, avian flu, swine flu, and zika; the most recent example of such outbreaks is COVID-19.

Yellow fever, dengue fever, Rift valley fever, and Zika virus infections have been among the commonly known infectious diseases occurring in France. For instance, in August 2018, the French National Reference Centre for Arboviruses (Institut Pasteur de la Guyane) reported an autochthonous (locally acquired) laboratory-confirmed case of yellow fever in an unvaccinated 47-year-old Swiss man in French Guiana. Also, Spain was one of the earliest countries where the epidemic was identified, but historians believe this was likely a result of wartime censorship. Currently, an outrageous global pandemic caused by the Novel Coronavirus, COVID-19, has taken over Spain. On 25th March 2020, Spain’s toll on this infection took over the number reported in China. The rapid surge in the number has brought the Spanish medical system to almost a brink of collapse with a chronic lack of medical supplies intended for testing treatment, and protection. Thus, the growing prevalence of infectious diseases is likely to boost the demand for pharmaceutical drug delivery systems in the region in the coming years.

In 2019, the Germany accounted for the largest share of the Europe pharmaceutical drug delivery market, and it is also expected to register the fastest CAGR during the forecast period. The growing number of the upcoming market players and increasing export of healthcare products and services, and ongoing technological advancements are the key factors supporting the largest share of this country in the regional market.

EUROPE PHARMACEUTICAL DRUG DELIVERY

– MARKET SEGMENTATION

By Route of Administration

• Oral Drug Delivery
• Injectable Drug Delivery
• Topical Drug Delivery
• Ocular Drug Delivery
• Pulmonary Drug Delivery
• Nasal Drug Delivery
• Transmucosal Drug Delivery
• Implantable Drug Delivery

By Application

• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
• Other Applications

By End User

• Hospitals
• Home Care Settings
• ASC/Clinics
• Other End Users

By Geography

• Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain

Company Profiles

• Bayer AG
• GlaxoSmithKline plc,
• MERCK KGaA
• Pfizer Inc.
• Novartis AG

Europe Pharmaceutical Drug Delivery Report Scope